DRAK1 overexpression 293T lysate (whole cell) (ab94107)

Overview

  • Product nameDRAK1 overexpression 293T lysate (whole cell)
  • Description
    DRAK1 overexpression lysate
  • General notesab94107 is a 293T cell transfected lysate in which Human DRAK1 has been transiently over-expressed using a pCMV-DRAK1 plasmid. The lysate is provided in 1X Sample Buffer. Note: For more details about how the transfected lysate was prepared view preparation notes
  • Tested applicationsSuitable for: WBmore details

Properties

  • BackgroundFunction: Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species. Tissue specificity: Highly expressed in placenta. Lower levels in heart, lung, skeletal muscle, kidney and pancreas. Similarity: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. DAP kinase subfamily. Contains 1 protein kinase domain. PTM: Autophosphorylated.

Associated products

Applications

Our Abpromise guarantee covers the use of ab94107 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use at an assay dependent dilution.

DRAK1 overexpression 293T lysate (whole cell) images

  • ab94107 at 15µg/lane on an SDS-PAGE gel
  • All lanes : Anti-DRAK1 antibody (ab56507) at 1/500 dilution

    Lane 1 : DRAK1 overexpression 293T lysate (whole cell) (ab94107)
    Lane 2 : 293T non-transfected lysate

    Lysates/proteins at 25 µg per lane.

    Secondary
    Goat Anti-mouse IgG (H and L) HRP conjugated at 1/2500 dilution

References for DRAK1 overexpression 293T lysate (whole cell) (ab94107)

ab94107 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Questions for ab94107.
Please use the link above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"